Reaction Details Report a problem with these data
Target
Leukotriene C4 synthase
Ligand
BDBM223265
Substrate
n/a
Meas. Tech.
In Vitro hLTC4 Synthase Enzyme Assay
IC50
356±n/a nM
Citation
 Ronn, R; Lindh, CJ; Ringberg, E; Andersson, HB; Nilsson, P; Schaal, WR; Munck af Rosenschöld, M; Nikitidis, A; Nikitidis, G; Johannesson, P; Tyrchan, C Compounds and uses US Patent  US9657001 Publication Date 5/23/2017 
Target
Name:
Leukotriene C4 synthase
Synonyms:
LTC4 synthase | LTC4S | LTC4S_HUMAN | Leukotriene-C(4) synthase
Type:
PROTEIN
Mol. Mass.:
16575.59
Organism:
Homo sapiens (Human)
Description:
ChEMBL_961179
Residue:
150
Sequence:
MKDEVALLAAVTLLGVLLQAYFSLQVISARRAFRVSPPLTTGPPEFERVYRAQVNCSEYFPLFLATLWVAGIFFHEGAAALCGLVYLFARLRYFQGYARSAQLRLAPLYASARALWLLVALAALGLLAHFLPAALRAALLGRLRTLLPWA
  
Inhibitor
Name:
BDBM223265
Synonyms:
2-(5-((4-Chlorophenyl)(cyclopropylmethyl)amino)-3-methoxypicolinoyl)-N-(cyclopropylsulfonyl)-cyclopropanecarboxamide | US20160326143, 40 | US9657001, 40
Type:
Small Organic Molecule
Emp. Form.:
C24H26ClN3O5S
Mol. Mass.:
503.998
SMILES:
COc1cc(cnc1C(=O)C1CC1C(=O)NS(=O)(=O)C1CC1)N(CC1CC1)c1ccc(Cl)cc1
Structure:
Search PDB for entries with ligand similarity: